Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 43 filings·Updated 13 Oct 2026
Showing 10 of 43 filings.
13 Oct 20261 filing
Company UpdateChange in Management

Independent Director K.S. Vaidyanathan resigns from Indrayani Biotech for personal reasons, effective 13 Oct 2026.

Resignation of Independent Director

  • Resignation of independent director K.S. Vaidyanathan from Indrayani Biotech Ltd.
  • Effective from close of business hours on 13 October 2026.
  • Reason: Personal reasons.
  • Directorships in other listed entities: Nil.
  • Membership of board committees in other listed entities: Nil.
  • No other material reasons beyond those stated in the resignation letter.
Filed 17:27View Source
30 Sept 20261 filing
Board Meeting

Indrayani Biotech to hold board meeting on Oct 7, 2026 to review unaudited results and committee reconstitution

Meeting Details

  • Date of Board Meeting: 7 October 2026 (Wednesday). Time and venue not disclosed.

Key Agenda Items

  • Unaudited standalone and consolidated results for quarter ended June 30, 2026, with Limited Review Report by statutory auditors.
  • Reconstitution of various Committees of the Board.

Other Notes

  • Trading window closure details not specified.
Filed 18:04View Source
29 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Indrayani Biotech Ltd: Closure of Trading Window from October 01, 2026 until 48 hours after the declaration of unaudited financial statements for the quarter and half year ending September 30, 2026

Indrayani Biotech Ltd: Closure of Trading Window from October 01, 2026 until 48 hours after the declaration of unaudited financial statements for the quarter and half year ending September 30, 2026

Filed 12:31View Source
15 Sept 20261 filing
Company UpdateNewspaper Publication

News Paper Publication as per Regulation 84 of SEBI(Issue of Capital and Disclosure Requirements), 2018 with respect to Rights Issue.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 11:56View Source
9 Sept 20263 filings
Company UpdateGeneral

Indrayani Biotech Rights Issue: up to ₹4,878.88 Lakhs; record date 28 Apr 2026

Rights Issue details

  • Rights issue up to 32,525,897 partly paid-up Equity Shares at ₹15 each, aggregating ₹4,878.88 Lakhs.
  • Record Date: 28 April 2026.
  • Open date: 15 September 2026; Close date: 14 October 2026; ASBA process.
  • Issue price ₹15 per share, including ₹5 premium; ₹3.75 due on application.

Use of proceeds and allocation

  • Net proceeds ₹4,803.88 Lakhs after ₹75.00 Lakhs expenses.
  • Allocation of net proceeds: WC 42.98%; promoter 10.41%; BIPL 26.54%; general corporate 20.07%.
  • Deployment FY2026-27: WC ₹2,064.64 L; promoter ₹500 L; BIPL ₹1,275 L; general ₹964.24 L.

Governance and promoter participation

  • Rights Issue Committee approved LOF; LOF dated 09 Sep 2026.
  • Promoter loan of ₹548 L to be adjusted against entitlement; up to ₹500 L used; no cash proceeds.
  • Minimum public shareholding to be maintained; delisting not intended.
Filed 20:29View Source
Corp. ActionBonds / Right issue

Indrayani Biotech revises partly paid-up rights issue schedule to Sep 15–Oct 14, 2026

Rights Issue Schedule

  • Partly paid-up equity rights issue; schedule revised by Rights Issue Committee on Sep 9, 2026.
  • Open window now from Sep 15, 2026 to Oct 14, 2026.
  • Last date for on-market renunciation updated to Oct 08, 2026.
  • LOF and related documents to be uploaded on BSE site and company site.
Filed 20:22View Source
Company UpdateAppointment of Company Secretary / Compliance Officer

Indrayani Biotech appoints C.S. Shanmuga Sundar as Company Secretary & Compliance Officer, effective 9 Sept 2026

Appointment details

  • Mr. C.S. Shanmuga Sundar appointed as Company Secretary & Compliance Officer.
  • Effective date of appointment: 09 September 2026.
  • Reason: appointment following resignation of Ms. Ramya Ravi on 03 June 2026.
  • Qualified Company Secretary; ACS qualification achieved 27 April 2019; previously CS at Peiner Smag Machinery.
  • Disclosure: Not related to directors.
Filed 19:05View Source
7 Sept 20262 filings
Company UpdateGeneral

Indrayani Biotech: Secretarial Auditor resigns effective 06 August 2026; new appointment to be considered

Resignation of Secretarial Auditor

  • K. Ravichandran resigned as Secretarial Auditor, effective 06 August 2026, due to personal reasons.
  • Audit Committee and Board will consider and appoint a new Secretarial Auditor in due course.
  • Intimation of appointment will be provided once approved.
  • Name of outgoing auditor: K. Ravichandran (ACS12838, COP 3207).
  • Disclosure under Regulation 30 enclosed as Annexure A with resignation letter.
Filed 18:42View Source
Company UpdateGeneral

Indrayani Biotech gets 2-month extension to hold AGM for FY2025-26 by 30 Nov 2026

AGM extension and regulatory approval

  • ROC granted a 2-month extension to 30 November 2026 for AGM FY2025-26.
  • Extension under Section 96(1) of the Companies Act, 2013.
  • Reason: extension sought due to capital restructuring planning, including a Rights Issue.
  • Board to finalize exact AGM date within extended window and inform stock exchange.
  • Accounting year end 31 March 2026; ROC order dated 04 September 2026.
  • Application SRN AC5569272 submitted on 27 August 2026.
  • Note: extension is subject to ROC approval and compliance.
  • Management will communicate further updates to the stock exchange.
Filed 17:46View Source
20 Aug 20261 filing
Company UpdateNewspaper Publication

News paper Publication of audited financials results (Standalone & Consolidated) for quarter and year ended March 31, 2026.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 17:34View Source
Showing 10 of 43 filings